	US 12,037,598 B2
	Cross-species compatible adeno-associated virus compositions and methods of use thereof
Aravind Asokan, Durham, NC (US); Trevor Gonzalez, Durham, NC (US); and Lawrence Patrick Havlik, Durham, NC (US)
Assigned to Duke University, Durham, NC (US)
Filed by Duke University, Durham, NC (US)
Filed on Sep. 26, 2023, as Appl. No. 18/474,533.
Application 18/474,533 is a continuation of application No. 17/922,962, previously published as PCT/US2021/030937, filed on May 5, 2021.
Claims priority of provisional application 63/020,062, filed on May 5, 2020.
Prior Publication US 2024/0076695 A1, Mar. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/86 (2006.01); C07K 14/005 (2006.01)

CPC C12N 15/86 (2013.01) [C07K 14/005 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14143 (2013.01)]

20 Claims

1. An adeno-associated virus (AAV) vector comprising an AAV capsid protein, wherein the AAV capsid protein comprises the amino acid sequence of SEQ ID NO: 14.